STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Beyond Air, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Robert Scott Goodman, a director of Beyond Air, Inc. (XAIR), received a grant of stock options on 08/14/2025. The option grant is for 3,750 stock options with an exercise price of $2.45 per share and an expiration date of 08/14/2035. The option vests 25% on December 31, 2025, with the remainder vesting in equal annual installments on each December 31 for the next three years. After the grant, the reporting person beneficially owns 5,750 shares of common stock, which includes an additional 2,000 stock split-adjusted shares noted in the filing.

Positive

  • Option grant disclosed: 3,750 stock options granted at an exercise price of $2.45 with expiration on 08/14/2035.
  • Vesting schedule provided: 25% vests on 12/31/2025, remainder vests in equal annual installments over the next three years.
  • Post-transaction ownership: Reporting person beneficially owns 5,750 shares, including 2,000 stock split-adjusted shares.

Negative

  • None.

Insights

TL;DR: Routine director option grant aligns management incentives; vesting schedule spans four years, adding retention incentives.

The filing documents a standard option award to a director: 3,750 options at $2.45, exercisable through 08/14/2035, with time-based vesting beginning 12/31/2025. Such grants are common practice to align board members with shareholder interests and to promote retention. The reported post-transaction beneficial ownership is 5,750 shares, which includes a 2,000 share adjustment from a stock split. No cash purchases, sales, or derivative disposals are reported. Based solely on the filing, the transaction is routine and not materially dilutive at reported amounts.

TL;DR: Disclosure shows a time‑based option award with clear vesting and exercise terms; impact to capital structure appears minor from disclosed figures.

The Form 4 records an option grant dated 08/14/2025 for 3,750 stock options at a $2.45 exercise price, expiring 08/14/2035. Vesting is 25% on 12/31/2025, then in equal annual installments over three years. The reporting person holds 5,750 shares after the transaction. The filing does not report any exercised or disposed options, cash proceeds, or any additional compensatory arrangements beyond the vesting schedule and split-adjusted holdings. From an investor-materiality perspective, this is a routine insider compensation disclosure.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Goodman Robert Scott

(Last) (First) (Middle)
C/O BEYOND AIR, INC.
900 STEWART AVENUE, SUITE 301

(Street)
GARDEN CITY NY 11530

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Beyond Air, Inc. [ XAIR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to buy) $2.45 08/14/2025 A 3,750 (1) 08/14/2035 Common Stock 3,750 $0 5,750(2) D
Explanation of Responses:
1. The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2025, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full.
2. Includes additional 2,000 stock split adjusted shares of common stock held by the reporting person.
/s/ Robert Scott Goodman 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Robert Scott Goodman report on Form 4 for Beyond Air (XAIR)?

The Form 4 reports a grant of 3,750 stock options on 08/14/2025 with an exercise price of $2.45 and expiration 08/14/2035.

How does the option vest according to the Form 4?

The option vests 25% on December 31, 2025, with the remainder vesting in equal annual installments on December 31 of each of the following three years.

How many shares does the reporting person beneficially own after the transaction?

After the reported transaction, the reporting person beneficially owns 5,750 shares of common stock, which includes 2,000 stock split‑adjusted shares.

Was any cash paid or shares sold in this Form 4 filing?

No cash payment or sale of shares is reported; the filing documents an option grant (A) rather than an exercise or sale.

What is the relationship of the reporting person to Beyond Air, Inc.?

The reporting person, Robert Scott Goodman, is identified as a Director of Beyond Air, Inc.
Beyond Air Inc

NASDAQ:XAIR

XAIR Rankings

XAIR Latest News

XAIR Latest SEC Filings

XAIR Stock Data

10.25M
7.55M
11.57%
10.53%
6.12%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GARDEN CITY